Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Friday, June 2nd. Several other research firms also recently commented on AQXP. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Aquinox […]
